Panretin

Panretin is a brand name of alitretinoin topical, approved by the FDA in the following formulation(s):

PANRETIN (alitretinoin - gel; topical)

• 
  Manufacturer: EISAI INC
  
  Approval date: February 2, 1999
  
  Strength(s): EQ 0.1% BASE ^[RLD]

Has a generic version of Panretin been approved?

No. There is currently no therapeutically equivalent version of Panretin available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Panretin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Method for in vivo modulation of non-malignant skin-related processes with 9-cis-retinoic acid
  Patent 5,932,622
  Issued: August 3, 1999
  Inventor(s): Evans; Ronald M. & Mangelsdorf; David J. & Heyman; Richard A. & Boehm; Marcus F. & Eichele; Gregor & Thaller; Christina
  Assignee(s): The Salk Institute for Biological Studies
  Baylor College of Medicine
  Ligand Pharmaceuticals, Inc.
  A method for modulating non-malignant skin related disorders in a subject has been demonstrated with 9-cis retinoic acid. Wrinkling, acne, keratinization, differentiation and proliferation disorders are treated by administration of 9-cis retinoic acid alone or in a pharmaceutically acceptable carrier to a subject in need thereof.
  
  Patent expiration dates:
  
  
  • August 3, 2016
    
    ✓ 
    Patent use: TOPICAL TREATMENT OF CUTANEOUS LESIONS IN PATIENTS WITH AIDS-RELATED KAPOSI'S SARCOMA
  
  

See also...

• Panretin Consumer Information (Wolters Kluwer)
• Panretin Consumer Information (Cerner Multum)
• Panretin Topical Advanced Consumer Information (Micromedex)
• Panretin AHFS DI Monographs (ASHP)
• Alitretinoin Consumer Information (Wolters Kluwer)
• Alitretinoin topical Consumer Information (Cerner Multum)
• Alitretinoin Topical Advanced Consumer Information (Micromedex)
• Alitretinoin AHFS DI Monographs (ASHP)